Chronic exposure to benzene is associated with hematotoxicity and acute mye
logenous leukemia. Inhibition of topoisomerase II alpha (topo 11) has been
implicated in the development of benzene-induced cytogenetic aberrations. T
he purpose of this study was to determine the mechanism of topo 11 inhibiti
on by benzene metabolites. In a DNA cleavage/relaxation assay, topo 11 was
inhibited by p-benzoquinone and hydroquinone at 10 muM and 10 muM, respecti
vely. On peroxidase activation, Inhibition was seen with 4,4'-biphenol, hyd
roquinone, and catechol at 10 muM, 10 muM, and 30 muM, respectively. But, I
n no case was cleavable complex stabilization observed and the metabolites
appeared to act at an earlier step of the enzyme cycle. In support of this
conclusion, several metabolites antagonized etoposide-stabilized cleavable
complex formation and Inhibited topo R-DNA binding. It is therefore unlikel
y that benzene-induced acute myelogenous leukemia stems from events Invoked
for leukemogenic topo 11 cleavable complex-stabilizing antitumor agents. (
C) 2001 by The American Society of Hematology.